Cingulate Inc. (CING)

Nasdaq Pharmaceutical Pharmaceutical Preparations SIC: 2834
D
Pipeline Grade

Financial Position (from SEC Filings)

$16.5M
Cash & Equivalents
$6.9M
Quarterly Burn Rate
7 mo
Est. Cash Runway
$66M
Market Cap

Estimated from most recent SEC quarterly filing. View SEC filings

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

No upcoming catalysts detected for this company.

FDA-Related SEC Filings

DateTypeDescriptionLink
2026-06-02 8-K Cingulate Inc. (CING, CINGW) (CIK 0001862150) - EX-99.1 EDGAR

More Analysis

AI Stock Score

SEC EDGAR fundamental analysis with Claude AI & ChatGPT ratings for CING.

SEC EDGAR Filings

All SEC filings for Cingulate Inc. on EDGAR.

Full Calendar

View all upcoming FDA catalysts across all biotech companies.